82 related articles for article (PubMed ID: 16040852)
21. Gut-Derived Metabolites and Their Role in Immune Dysfunction in Chronic Kidney Disease.
Glorieux G; Gryp T; Perna A
Toxins (Basel); 2020 Apr; 12(4):. PubMed ID: 32290429
[TBL] [Abstract][Full Text] [Related]
22. Protein-Bound Uremic Toxins in Hemodialysis Patients Relate to Residual Kidney Function, Are Not Influenced by Convective Transport, and Do Not Relate to Outcome.
van Gelder MK; Middel IR; Vernooij RWM; Bots ML; Verhaar MC; Masereeuw R; Grooteman MP; Nubé MJ; van den Dorpel MA; Blankestijn PJ; Rookmaaker MB; Gerritsen KGF
Toxins (Basel); 2020 Apr; 12(4):. PubMed ID: 32272776
[TBL] [Abstract][Full Text] [Related]
23. Isolation and Quantification of Uremic Toxin Precursor-Generating Gut Bacteria in Chronic Kidney Disease Patients.
Gryp T; Huys GRB; Joossens M; Van Biesen W; Glorieux G; Vaneechoutte M
Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32183306
[TBL] [Abstract][Full Text] [Related]
24. Uraemic toxins and cardiovascular disease:
Vanholder R; Laecke SV; Verbeke F; Glorieux G; Biesen WV
NDT Plus; 2008 Feb; 1(1):2-10. PubMed ID: 30792775
[No Abstract] [Full Text] [Related]
25. Introduction to the
Vanholder R
Toxins (Basel); 2018 Sep; 10(10):. PubMed ID: 30257453
[No Abstract] [Full Text] [Related]
26. Cardiotoxicity of Uremic Toxins: A Driver of Cardiorenal Syndrome.
Lekawanvijit S
Toxins (Basel); 2018 Sep; 10(9):. PubMed ID: 30200452
[TBL] [Abstract][Full Text] [Related]
27. Biochemical and Clinical Impact of Organic Uremic Retention Solutes: A Comprehensive Update.
Vanholder R; Pletinck A; Schepers E; Glorieux G
Toxins (Basel); 2018 Jan; 10(1):. PubMed ID: 29316724
[TBL] [Abstract][Full Text] [Related]
28. Identification of Key Odorants in Used Disposable Absorbent Incontinence Products.
Hall G; Alenljung S; Forsgren-Brusk U
J Wound Ostomy Continence Nurs; 2017; 44(3):269-276. PubMed ID: 28328644
[TBL] [Abstract][Full Text] [Related]
29. Free and total p-cresol sulfate levels and infectious hospitalizations in hemodialysis patients in CHOICE and HEMO.
Banerjee T; Meyer TW; Shafi T; Hostetter TH; Melamed M; Zhu Y; Powe NR
Medicine (Baltimore); 2017 Feb; 96(6):e5799. PubMed ID: 28178126
[TBL] [Abstract][Full Text] [Related]
30. p-Cresyl Sulfate.
Gryp T; Vanholder R; Vaneechoutte M; Glorieux G
Toxins (Basel); 2017 Jan; 9(2):. PubMed ID: 28146081
[TBL] [Abstract][Full Text] [Related]
31. The pretransplant systemic metabolic profile reflects a risk of acute graft versus host disease after allogeneic stem cell transplantation.
Reikvam H; Hatfield K; Bruserud Ø
Metabolomics; 2016; 12(1):12. PubMed ID: 27829829
[TBL] [Abstract][Full Text] [Related]
32. Effect of probiotic and prebiotic fermented milk on skin and intestinal conditions in healthy young female students.
Mori N; Kano M; Masuoka N; Konno T; Suzuki Y; Miyazaki K; Ueki Y
Biosci Microbiota Food Health; 2016; 35(3):105-12. PubMed ID: 27508111
[TBL] [Abstract][Full Text] [Related]
33. Uremic Toxins - Novel Arrhythmogenic Factor in Chronic Kidney Disease - Related Atrial Fibrillation.
Huang SY; Chen YA; Chen SA; Chen YJ; Lin YK
Acta Cardiol Sin; 2016 May; 32(3):259-64. PubMed ID: 27274165
[TBL] [Abstract][Full Text] [Related]
34. Microbiota-Derived Phenylacetylglutamine Associates with Overall Mortality and Cardiovascular Disease in Patients with CKD.
Poesen R; Claes K; Evenepoel P; de Loor H; Augustijns P; Kuypers D; Meijers B
J Am Soc Nephrol; 2016 Nov; 27(11):3479-3487. PubMed ID: 27230658
[TBL] [Abstract][Full Text] [Related]
35. Proteomic Investigations into Hemodialysis Therapy.
Bonomini M; Sirolli V; Pieroni L; Felaco P; Amoroso L; Urbani A
Int J Mol Sci; 2015 Dec; 16(12):29508-21. PubMed ID: 26690416
[TBL] [Abstract][Full Text] [Related]
36. Role of the Gut Microbiome in Uremia: A Potential Therapeutic Target.
Ramezani A; Massy ZA; Meijers B; Evenepoel P; Vanholder R; Raj DS
Am J Kidney Dis; 2016 Mar; 67(3):483-98. PubMed ID: 26590448
[TBL] [Abstract][Full Text] [Related]
37. Chronic Kidney Disease and Fibrosis: The Role of Uremic Retention Solutes.
Mutsaers HA; Stribos EG; Glorieux G; Vanholder R; Olinga P
Front Med (Lausanne); 2015; 2():60. PubMed ID: 26380262
[TBL] [Abstract][Full Text] [Related]
38. Fiber supplementation lowers plasma p-cresol in chronic kidney disease patients.
Salmean YA; Segal MS; Palii SP; Dahl WJ
J Ren Nutr; 2015 May; 25(3):316-20. PubMed ID: 25446837
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of human drug-metabolising cytochrome P450 and UDP-glucuronosyltransferase enzyme activities in vitro by uremic toxins.
Barnes KJ; Rowland A; Polasek TM; Miners JO
Eur J Clin Pharmacol; 2014 Sep; 70(9):1097-106. PubMed ID: 24954688
[TBL] [Abstract][Full Text] [Related]
40. Human organic anion transporters function as a high-capacity transporter for p-cresyl sulfate, a uremic toxin.
Watanabe H; Sakaguchi Y; Sugimoto R; Kaneko K; Iwata H; Kotani S; Nakajima M; Ishima Y; Otagiri M; Maruyama T
Clin Exp Nephrol; 2014 Oct; 18(5):814-20. PubMed ID: 24185403
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
